Royalty Report: Drugs, Therapeutic, Pharmaceuticals – Collection: 1653


Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Drugs
  • Therapeutic
  • Pharmaceuticals
  • Cancer
  • Disease

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 1653

License Grant
The Company acquired rights to certain proprietary cancer and viral therapeutic technology.
Field of Use
The rights granted apply to the healthcare industry.

IPSCIO Record ID: 6734

License Grant
In connection with the issuance of the Class UA preferred stock, the Company has agreed to pay a royalty of the net proceeds of sale of any products sold by the Company employing technology acquired in exchange for the shares. The Company is a clinical-stage biopharmaceutical company focused primarily on the development of therapeutic products for the treatment of cancer.
Field of Use
The rights granted apply to the treatment of cancer in the medical industry.

IPSCIO Record ID: 2906

License Grant
The Licensee entered into an exclusive, worldwide License Agreement with the Licensor for an issued patent related to the therapeutics’ method of use in treating various forms of viral infection including, but not limited to HIV and influenza.  Any improvements to the inventions by the Licensor claimed in the Patent Rights shall be included in the terms of the agreement.
Field of Use
The rights granted apply to the healthcare industry relating to viral infection.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.